Yoel Bakas, Vice President of Sales, Americas, joins Mevion from Varian Medical Systems, where he oversaw strategic account development and has focused on medical devices sales for the past 17 years.
Scott Soehl, Vice President of International Sales, joins Mevion with more than 35 years of radiation oncology experience, having previously worked at Elekta and IMPAC Medical Systems.
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Curt Kienast, Vice President of Global Services, is promoted from within Mevion where he previously served as senior director of product development. Curt has more than 15 years of experience in health care quality and services.
Chris Dodge, Field Vice President, The Americas; Business Development & Customer Financing, joins Mevion with 30 years of medical device sales and marketing experience, having previously worked at Varian Medical Systems for the past 15 years.
George Rugg, Vice President of Business Development, is appointed from his previous position as Mevion’s vice president of global services. George’s career spans 30 years of working in the oncology field.
“The growth of our leadership team will continue support our mission to make proton therapy a clinical reality for cancer centers of all sizes,” said Jachinowski. “We look forward to leveraging the team’s extensive industry knowledge and experience as we partner with more and more customers and help cancer centers succeed throughout the entire proton therapy system lifecycle.”
About Mevion Medical Systems
Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with international offices in the Netherlands, Japan and China. For more information, please visit www.mevion.com.
About the MEVION S250 Series
The MEVION S250 Series is elegantly designed to deliver high-powered, efficient proton therapy treatments. Built upon the world’s only gantry-mounted proton accelerator and benefiting from Mevion’s patented direct beam technology, the MEVION S250 Series delivers on the therapeutic promise of proton therapy while enhancing beam quality, stability and uptime. The result is reduced system complexity, higher reliability and throughput, and lower capital and operating costs—making the MEVION S250 Series a compelling, financially viable solution for all cancer centers. The MEVION S250 Series includes:
· MEVION S250, offering highly stable, next-generation volumetric delivery capabilities
